Why is Eiko Lifescience falling/rising?

As of 29-Jul, Eiko Lifesciences Ltd is experiencing a price increase, currently at 55.06, which reflects a rise of 2.57 or 4.9%. Today's price summary indicates that the stock has outperformed its sector by 5.26% and has gained after two consecutive days of decline. It opened with a gain of 2.69% and reached an intraday high of Rs 58.5, marking an increase of 11.45%. Despite this positive movement, the stock has shown a negative return of -4.58% over the past week and -12.24% year-to-date, although it has gained 8.51% over the past month. The recent increase in promoter confidence, with a 0.51% rise in their stake, suggests a belief in the company's future, but the stock's long-term fundamentals remain weak, evidenced by a low average Return on Equity (ROE) of 2.82% and a significant drop in net sales.
Broader market context shows that while Eiko Lifesciences has outperformed its sector today, it has underperformed the benchmark index, Sensex, over the last year, which has seen a decline of only -0.02%. The stock's volatility today, with an intraday fluctuation of 6.11%, indicates a turbulent trading environment. Additionally, the falling investor participation, with a 31.94% decrease in delivery volume, raises concerns about sustained interest in the stock. Overall, while the recent price increase may be driven by short-term factors and promoter confidence, the broader context of underperformance and weak fundamentals suggests caution for investors.